文献速递烧伤创面修复

严重烧伤的病理生理学:系统视角下的新治疗机会

Pathophysiology of Severe Burn Injuries: New Therapeutic Opportunities From a Systems Perspective.
PubMed 文献 · J Burn Care Res · 2024-01-01

本文综述了烧伤研究历史并从系统视角讨论严重烧伤病理生理学,认为损伤相关分子模式、病原相关分子模式和神经传入信号的持续爆发导致过度炎症、免疫功能障碍、凝血病、高代谢和剧痛。作者提出早期恢复中枢神经系统对心血管功能的控制及内皮-糖萼-线粒体耦联可减轻继发性损伤,并介绍含腺苷、利多卡因和镁(ALM)的小容量液体疗法的早期研究。

要点

  • 严重烧伤引发强烈应激反应,合并多发伤时结局更差,女性结局较男性更差。
  • 缺乏有效药物治疗烧伤休克和继发性损伤进展,源于当前对症处理而非整合系统方法。
  • ALM小容量液体疗法在严重烧伤后支持心血管和肺功能方面显示一定前景。

核心结论

  • 严重烧伤表型源于损伤相关分子模式、病原相关分子模式和神经传入信号的快速持续爆发,导致过度炎症、免疫功能障碍、凝血病、高代谢和剧痛。
  • 若早期恢复中枢神经系统对心血管功能的控制及内皮-糖萼-线粒体耦联,继发性损伤过程可能被最小化。
  • 治疗目标是减少液体渗漏并维持组织氧灌注,将损伤表型转为愈合表型。
  • 目前尚无基于系统的疗法治疗严重烧伤。

研究设计与样本

  • 综述,简要回顾烧伤研究历史并从系统视角讨论严重烧伤病理生理学。

主要发现

  • 合并多发伤时患者结局似乎更差。
  • 基于性别的比较表明女性结局较男性更差。
  • 缺乏有效药物似乎源于当前对症处理而非更整合的系统方法。
  • 早期研究表明ALM疗法在严重烧伤后支持心血管和肺功能方面有一定前景。

临床怎么用

  • 未来研究将探讨ALM疗法治疗合并多发伤和性别差异的严重烧伤的能力,以及向人类转化的潜力。

局限性

  • 目前尚无基于系统的疗法治疗严重烧伤。
  • ALM疗法的早期研究仅显示一定前景,未来需研究其对合并多发伤和性别差异的严重烧伤的治疗能力及向人类转化的潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Severe burn injury elicits a profound stress response with the potential for high morbidity and mortality. If polytrauma is present, patient outcomes appear to be worse. Sex-based comparisons indicate females have worse outcomes than males. There are few effective drug therapies to treat burn shock and secondary injury progression. The lack of effective drugs appears to arise from the current treat-as-you-go approach rather than a more integrated systems approach. In this review, we present a brief history of burns research and discuss its pathophysiology from a systems' perspective. The severe burn injury phenotype appears to develop from a rapid and relentless barrage of damage-associated molecular patterns, pathogen-associated molecular patterns, and neural afferent signals, which leads to a state of hyperinflammation, immune dysfunction, coagulopathy, hypermetabolism, and intense pain. We propose that if the central nervous system control of cardiovascular function and endothelial-glycocalyx-mitochondrial coupling can be restored early, these secondary injury processes may be minimized. The therapeutic goal is to switch the injury phenotype to a healing phenotype by reducing fluid leak and maintaining tissue O2 perfusion. Currently, no systems-based therapies exist to treat severe burns. We have been developing a small-volume fluid therapy comprising adenosine, lidocaine, and magnesium (ALM) to treat hemorrhagic shock, traumatic brain injury, and sepsis. Our early studies indicate that the ALM therapy holds some promise in supporting cardiovascular and pulmonary functions following severe burns. Future research will investigate the ability of ALM therapy to treat severe burns with polytrauma and sex disparities, and potential translation to humans.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Dobson GP, Morris JL, Letson HL, et al. Pathophysiology of Severe Burn Injuries: New Therapeutic Opportunities From a Systems Perspective. J Burn Care Res. 2024. PMID: 38517382. doi:10.1093/jbcr/irae049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。